CIGDEM ILERI1, ZEKERIYA DOGAN2, BESTE OZBEN2, IPEK MIDI3, NEVIN PAZARCI4
NOVEMBER 30, 2023
Clinical Neuroscience - 2023;76(11-12)
DOI: https://doi.org/10.18071/isz.76.0365
Journal Article
Szöveg nagyítása:
A stroke may be the first presentation of atrial fibrillation (AF). Approximately onefourth of ischemic stroke patients are newly diagnosed with AF1. The term, AF diagnosed after stroke (AFDAS) is used for both previously undetected, asymptomatic AF and poststroke AF2.
In acute ischemic stroke, structural brain lesions, especially those with cortical involvement, may lead to autonomic dysregulation and inflammation3. Although the pathophysiology has not been defined clearly, autonomic dysfunction and inflammation may play a role in the development of AF by lowering the cardiac arrhythmogenic threshold4. AF has been detected in more than half of the cases within 3 days after admission for ischemic stroke5. The mean time of AF diagnosis has ranged between 3 to 77 days after stroke. Meanwhile, AF detected earlier after the stroke has been suggested to be the consequence of the stroke, not the cause of the stroke2.
AFDAS patients are believed to have a more benign disease profile compared to patients with known AF (KAF). In a metaanalysis, it has been shown that AFDAS patients have a better vascular profile and lower comorbidities such as hypertension, diabetes, hyperlipidemia, coronary artery disease, heart failure, and previous stroke4. The duration of AF periods diagnosed after stroke is less than 30 seconds in approximately half of the patients, which implies that AF burden is lower in AFDAS patients6. Moreover, the ischemic recurrence of AFDAS is shown to be less, compared to patients with KAF before stroke7.
The aim of our study was to investigate the characteristics and mortality differences of the patients with strokes that preceded or occurred after the diagnosis of AF.
Methods
The investigation conformed to the principles outlined in the Declaration of Helsinki. All participants gave written informed consent. The study was approved by the ethics committee of Marmara University School of Medicine.
Study population
One hundred and thirtyfour patients presenting with acute ischemic stroke documented by cranial imaging were consecutively included in the study. The TOAST classification system was used to define the stroke subtypes8. National Institutes of Health Stroke Scale (NIHSS) scores of patients were noted at the time of hospitalization. Patients with transient ischemic attacks (TIA) were not included in our study.
Patients were evaluated for the presence of comorbidities, including hypertension, hyperlipidemia, diabetes, and coronary artery disease. Blood samples for high sensitive (hs) Creactive protein (CRP), hscardiac troponin I (hscTnI), and Nterminal probrain natriuretic peptide (NTproBNP) levels were noted. All patients underwent a transthoracic echocardiographic study by a Philips Epic echocardiography device (Philips Medical Systems, Andover, MA, USA) by an experienced cardiologist within the first three days following acute ischemic stroke. Conventional echocardiographic measurements were performed by the recommendations of the American Society of Echocardiography guidelines9. LVEF was assessed by biplane Simpson’s method.
Electrocardiography (ECG) was obtained from each patient daily. Ambulatory ECG monitoring was performed in patients with sinus rhythm (SR) to explore AF or other arrhythmias within the first seven days following acute ischemic stroke. The ECG recordings were analyzed by an experienced cardiologist. Patients who had newly documented AF rhythm lasting more than 30 seconds in ambulatory ECG monitoring or daily 12lead ECG were classified as AFDAS, while patients who had known AF with anticoagulant therapy were grouped as KAF based on patientreported medical history and prior available medical records. AFs that were detected at the time of hospitalization that had not been diagnosed and treated before this ischemic stroke event, and that also occurred during the hospitalization period were also categorized as AFDAS.
Cranial images of the patients were reevaluated by experienced neurologists who were blind to patients’ characteristics to determine whether there was an insular cortex involvement.
All patients were followed for 1 year to obtain allcause mortality, cardiac mortality and neurogenic mortality.
Statistical analysis
Statistical analyses were performed by statistical software (SPSS 21.0 for windows, Chicago, IL). The distribution of data was assessed by using onesample Kolmogorov–Smirnov test. Continuous data were expressed as mean ± SD while categorical data were expressed as numbers or percentages. Chisquared test was used for the comparison of categorical variables. Student’s ttest or ANOVA was used to compare the normally distributed continuous variables while the MannWhitney U test or KruskalWallis test was used to compare the nonparametric continuous variables. Post hoc analyses were performed using the Bonferroni test when an overall statistical significance was determined. Logistic regression analysis was performed to explore the predictors of allcause mortality. Statistical significance was accepted as a Pvalue less than 0.05.
Table 1. The characteristics of the patients
KAF: known atrial fibrillation, AFDAS: atrial fibrillation diagnosed after stroke, SR: sinus rhythm, NIHSS: National Institutes of Health
Stroke Scale PostHoc analysis: * denotes statistical significance versus patients with sinus rhythm
Results
One hundred and thirtyfour consecutive ischemic stroke patients (66.1 ± 14.2 years old, n=73 male) were includ ed in the study. Twentytwo patients (16.4%) had KAF while AF was detected newly in 38 patients (28.4%), who were grouped as AFDAS. The remaining 74 patients (55.2%) had SR. The general characteristics of the pa tients according to cardiac rhythm are shown in Table 1. Patients with KAF and AFDAS were significantly older compared to the patients with SR, while there was no significant difference in age between KAF and AFDAS patients. KAF patients had higher CHA2DS2VASc scores and more insular cortex involvement than the SR group, while CHA2DS2VASc scores and insular cortex involve ment were similar between AFDAS and SR patients. There were no significant differences in the comorbidi ties and NIHSS scores among patients. Stroke patients with KAF and AFDAS were using betablockers more than SR patients.
Table 2. The laboratory parameters and conventional transthoracic echocardiographic measures of the patients
KAF: known atrial fibrillation, AFDAS: atrial fibrillation diagnosed after stroke, SR: sinus rhythm, LDL: Low-density lipoprotein, hs-cTnI: High-sensitive cardiac Troponin I, hs-CRP: High-sensitive C-reactive protein, NT-proBNP: N terminal pro-brain natriuretic peptide, LAVI: Left atrial volume index, LVEF: left ventricular ejection fraction, E/e’: the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity
PostHoc analysis: * denotes statistical significance versus patients with sinus rhythm
+ denotes statistical significance versus patients with atrial fibrillation diagnosed after a stroke
The laboratory and conventional echocardiographic parameters of the patients are listed in Table 2. hscTnI was elevated in all groups while the SR group had the highest mean. hsCRP levels were higher in KAF patients compared to patients with SR. While AFDAS patients had also higher hsCRP levels than patients with SR, the difference was not statistically signifi cant. KAF and AFDAS patients had sig nificantly larger left atriums compared to patients with SR. Although there were no significant differences in the left ventricu lar ejection fraction values of the patients, the KAF group had significantly higher NTproBNP and E/e’ compared to the SR group, while AFDAS and SR patients had similar NTproBNP and E/e’. During the oneyear followup period, 35 stroke patients died (12 patients in the KAF group, 11 in the AFDAS group, and 12 in the SR group). KAF patients had significantly higher allcause and cardiac mortality rates compared to both AFDAS patients and SR patients, while the AFDAS group had similar allcause and cardiac mortality rates to the SR group (Table 3).
Table 3. One-year mortality rates of the patients
KAF: known atrial fibrillation, AFDAS: atrial fibrillation diagnosed after stroke, SR: sinus rhythm
PostHoc analysis: * denotes statistical significance versus patients with sinus rhythm
+ denotes statistical significance versus patients with atrial fibrillation diagnosed after a stroke
The characteristics, laboratory parameters, and con ventional transthoracic echocardiographic measures of stroke patients according to mortality status are shown in Table 4. These patients were older, had higher CHA2 DS2VASc and NIHSS scores, hscTnI, and hsCRP levels, with more insular cortex involvement, and larger left atrium.
Table 4. The characteristics of the patients according to all-cause mortality
NIHSS: National Institutes of Health Stroke Scale, hs-cTnI: High-sensitive cardiac Troponin I, hs-CRP: High-sensitive C-reactive protein, LAVI: Left atrial volume index, LVEF: left ventricular ejection fraction, KAF: known atrial fibrillation, AFDAS: atrial fibrillation diagnosed after stroke, SR: sinus rhythm
Univariable and multivariable logistic regression anal yses were modeled to explore the predictors of allcause of mortality (Table 5). Logistic regression analysis re vealed KAF as an independent predictor when adjusted by age, sex, CHA2DS2VASc and NIHSS scores, and in sular cortex involvement. While AFDAS increased the mortality risk compared to SR, the differences were not significant in univariable and multivariable models.
Table 5. Univariable and multivariable logistic regression analysis showing the predictors of all-cause mortality
KAF: known atrial fibrillation, AFDAS: atrial fibrillation diagnosed after stroke, SR: sinus rhythm, NIHSS: National Institutes of Health Stroke Scale
Discussion
In our study, we explored the characteristics and mortal ity differences between KAF and AFDAS patients. We found that while both AFDAS and KAF patients were significantly older than the patients with SR, CHA2 DS2VASc scores, insular cortex involvement, NIHSS scores, and comorbidities were similar between AFDAS and SR patients. Interestingly, only KAF was associated with mortality in both univariable and multivariable analysis, while AFDAS patients had similar mortality rates to SR patients.
Cardiovascular diseases are more common in both ischemic stroke and AF. However, cardiovascular dis ease and mortality rates are not the same in every AF patient. Underlying cardiovascular diseases and oneyear composite cardiovascular outcomes were observed to be higher in KAF patients than in AFDAS patients, but KAF was not found to be an independent predictor of outcomes10. Since comorbidities and structural heart dis ease are noted less in AFDAS patients, it is believed to be triggered by neurogenic mechanisms developed after stroke3, 11. Major factors such as autonomic dysfunction, increased catecholamine discharge, neurogenic cardiac injury, and systemic inflammation leading to atrial elec trical and structural remodeling after acute stroke may facilitate the occurrence and maintenance of AF2. In our study, coronary artery disease and other comorbidities such as hypertension, diabetes, and hyperlipidemia were found to be similar among groups.
There are conflicting results in the literature regarding the outcome of AFDAS. For example, in a study with 5year followup of stroke patients, the highest annual mortality was found in patients with newly diagnosed AF within the first 6 months after stroke12. Also, Yang XMet al showed that AFDAS patients had similar stroke re currence and mortality rates when compared to KAF but higher than SR13. In our study, mortality in the AFDAS group was found to be similar to sinus rhythm patients, which may be due to the more benign vascular profile of AFDAS as we predicted. In addition, little is known about the pathophysiology of AFDAS, but in recent stud ies, it is thought to have two subgroups, neurogenic and cardiogenic14. The cardiogenic AFDAS group with pre existing but newly diagnosed AF after stroke has atrial cardiopathy and structural heart disease15. In addition, in the neurogenic AFDAS group without structural heart disease, AF is thought to be triggered entirely by auto nomic and inflammatory mechanisms14. The heteroge neity of AFDAS may explain the difference in outcome between studies.
Although it has not been revealed yet, it is hypothe sized that large brain infarcts seen in moderate and se vere strokes cause more autonomic dysregulation and in flammation and therefore cause more AFDAS11, 15, 16. We measured stroke severity, which correlates with infarct size, but we couldn’t find any difference in NIHSS scores among the groups in our study. Studies about AFDAS showed a particularly remarkable involvement of the in sular cortex, which plays a role in the regulation of the autonomic nervous system3, 11. Although there are con flicting reports on which of the right and left hemisphere involvement increases sympathetic activity, increasing numbers of studies show that in insular cortex involvement the heart rate variability decrease and the risk of
AF increase significantly11, 17–19. In our study, significantly higher insular cortex involvement was found in KAF patients while there was no difference between AFDAS and SR groups in terms of insular cortex involvement.
In addition, autonomic dysfunction is thought to cause not only post-stroke AF but also myocardial injury: socalled neurogenic myocardial stunning (NSM)20. There are opinions that myocardial damage presenting with troponin elevation after stroke may be a predictor of AF21. In our study, hs-cTnI was found to be high in all groups, while the SR group had the highest mean and EF values were similar between groups. Since NSM is a reversible myocardial damage diagnosed with reduced EF, regional wall motion abnormality, ECG changes, and high troponin values, it is not possible to make a conclusion based on the data available in our study22, 23.
Approximately half of the ischemic strokes detected in the Penn Atrial Fibrillation Free study (PAFF) were detected within 6 months period before the diagnosis of AF. Most strokes occur on the day of diagnosis of AF and within the next 7 days24. In our study, approximately one-third of the patients were diagnosed with AFDAS, similarly in the first week. These patients had similar CHA2DS2VASc scores to patients with SR. However, the CHA2DS2VAS scores of KAF patients were higher than in the SR group. In another study investigating new AF with prolonged ECG monitoring more than one week after stroke, NIHSS and CHA2DS2VAS scores were found to be similar in groups with a previous diagnosis of AF and newly diagnosed AF25. It may be important on which day the diagnosis of AF is made after the stroke.
Limitations
First, a small sample size and a relatively short follow-up period are limitations of our study. Second, it has recently been revealed that AFDAS is a heterogeneous group and includes two different clinical entities as cardiogenic and neurogenic AFDAS. Due to the small number of AFDAS patients, we could not investigate the differences between these subgroups. Third, we excluded TIA because it was diagnosed with a subjective neurological evaluation, which might cause misdiagnosis of AFDAS. Fourth, AF might be underestimated as the patients did not undergo prolonged ambulatory ECG monitoring.
Conclusion
In summary, AFDAS patients were older but had similar insular cortex involvement, CHA2DS2VAS, and NIHSS score to SR patients; the insular cortex involvement and CHA2DS2VAS score were higher in the KAF group than in SR patients; AFDAS patients had similar mortality rates to SR patients; KAF patients had increased mortality compared to SR patients; mortality of the KAF group was independent of age, sex, insular cortex involvement, CHA2DS2VAS, and NIHSS scores.
AFDAS patients have similar CHA2DS2VAS scores and mortality rates to patients with sinus rhythm, which supports the hypothesis that AFDAS might be a relatively benign form of AF. However, having a KAF diagnosis before an ischemic stroke is an independent predictor of all-cause mortality.
Clinical Neuroscience
Immune-checkpoint inhibitors (ICI) are effective drugs in cancer treatment that block immune checkpoints and stimulate an attack on cancer cells. However, various side effects were reported with ICIs. Peripheral nervous system (PNS) side effects are three times more frequent than those in the central nervous system. A 63-year-old male patient was admitted to our department with a 10-day history of dyspnea, diplopia, and generalized weakness.
Clinical Neuroscience
The purpose of the present study was to evaluate ocular vestibular evoked myogenic potential, cervical vestibular evoked myogenic potential, and brainstem auditory evoked potential response characteristics and to understand the pathophysiology of vestibular dysfunction in female migraineurs with vertigo symptoms. We also aimed to assess the electrophysiological diagnostic significance of the VEMP responses in vestibular migraine.
Clinical Neuroscience
Hippocampi are the structures located in the medial depths of both temporal lobes, mainly responsible for memory, navigation and regulation of emotions, and activated during the processing of pain and the modification of nociceptive stimuli. Chronic pain is thought to have stress-like detrimental modulatory effects on the hippocampal neurogenesis, and adults with chronic pain have been showed to have lower hippocampal volumes. a
Clinical Neuroscience
Airbag induced injuries such as skull and cervical spine fractures, epidural and subdural hematomas, atlantooccipital dislocations or brainstem lacerations are already documented in published literature, however, no previous case have been published about a penetrating foreign body of the skull base following airbag deployment. Removal of an intracranial foreign body is very dangerous and difficult.
Clinical Neuroscience
Although headaches are often comorbid with psychological symptoms, the underlying psychological processes, e.g. the role of personality dimensions as headache determinants remains unclear. Studies found associations between headaches and various personality traits; according to the Big Five model of personality, persons suffering from headaches exhibit a higher rate in neuroticism, while a lower rate in extraversion, openness to experiences and positive emotions.
Clinical Neuroscience
[ Thrombolysis and/or thrombectomy have been proven effective in the treatment of acute ischemic stroke. Due to the narrow time window, the number of patients suitable for these treatments is low. The main limitation is the pre-hospital stage, few people call an ambulance in time. The delay may be caused by the population’s insufficient health knowledge, but also by the loneliness and isolation of the population most prone to stroke. Among the latter, there are many grandparents who spend considerable time with their grandchildren. This gave rise to the idea of educating even younger children about the symptoms of a stroke, enabling them to call an ambulance if necessary. To this end, we adapted the Angels Initiative project previously tested in Greece. The Hungarian pilot study Budapest District XII. took place in district kindergartens. The Angels’ original role-playing program could not be implemented due to the COVID epidemic, so the necessity called for a new, Hungarian version: the online “Stroke Ovi” program. We introduced this in several stages, and in the third we also carried out an impact study.
We adapted the Angels Initiative’s international program and its Hungarian translation to our program. We prepared the original, live role-playing form, with a parent meeting in the selected “test kindergarten”. Due to the uncertainly lingering impact of the COVID epidemic, we reevaluated our plan, using the Hungarian storybook and take-home workbook created in the meantime, we developed our own online version in several kindergartens in Budapest. We held 10 and then 25 minute sessions a week for 5 weeks. In the third educational cycle, which always targets new groups, we already examined the impact of the program by taking pre- and post-tests, in which not only the children but also their parents participated. In addition to neurologists and kindergarten teachers, we also included psychologists and speech therapists in our work, because we believed that in a social environment that includes parents and children, results can only be achieved through multidisciplinary cooperation.
In the third cycle of the program, tests were taken before (pre-test) and after (post-test) among children and their parents. We only took into account those answers where we received an evaluable answer in the survey before and after the program. Our most important results: 1. there was no negative change in any question, so it was not the case that the total score of any question in the pre-test was higher than in the post-test. 2. The children learned that not only adults can call the ambulance. 3. Before the program, all children were already aware that if “someone is very ill”, the ambulance should be called. 4. Among the questions about stroke symptoms, it is important that hemiparesis, facial paresis and speech/language disorder are clear symptoms for children. Based on the parental questionnaires, the knowledge of the adults can be judged to be very good. The same number of correct answers were received during the pre-test and the post-test, on the basis of which we could not calculate a transfer effect. However, it is important that the parents considered the program useful, motivating and important for the children, so cooperation can be expected in the future.
The Hungarian “Stroke Ovi” program has so far proven to be clearly effective. This was proven by the impact assessments even if, instead of the original role-playing game, we implemented it “only” online due to the COVID epidemic. This constraint also forced and created a new “Hungarian version”. Despite the small number of samples caused by the circumstances, we consider this positive effect to be measurable. However, as the main result and evidence, we evaluated the children’s reaction, which took shape in spontaneous drawings and displayed professional values in addition to positive emotional reactions, such as the drawing of ambulances, the recurring representation of the 112 number. With the involvement of the media, we think online education is also a good option in the series of stroke campaigns, but we think the original role-playing form is really effective. At the same time, we can see that the application of the new method requires great caution due to the education of developing children. For this reason, results can only be achieved through social and multidisciplinary cooperation involving neurologists, psychologists, kindergarten teachers, and parents.]
Clinical Neuroscience
Background: This overview provides a summary of the applications of transcranial Doppler (TCD) in ischemic stroke. Results: A fast-track neurovascular ultrasound protocol has been developed for detecting occlusion or stenosis. The technique is more reliable in the carotid area than in the posterior circulation. By monitoring the pulsatility index the increased intracranial pressure can be diagnosed. TIBI score was developed for grading residual flow. TCD has been shown to accurately predict complete or any recanalization. Regarding recanalization, TCD has a sensitivity of 92%, a specificity of 88%, a positive predictive value of 96%, a negative predictive value of 78% and an overall accuracy of 91%, respectively. Sonothrombolysis seemed to be a promising application but randomized controlled trials have shown that it does not improve clinical outcome. TCD examination can detect microembolic signals (MES) which are associated with an increased risk of stroke. Microemboli were detected in symptomatic and asymptomatic carotid artery stenosis and during carotid endarterectomy. The number of microemboli can be decreased by antithrombotic therapy. Contrast enchanced examination and Valsalva maneuver with continuous TCD monitoring can accurately screen for right-to-left shunt.
Clinical Neuroscience
Rapid changes of stroke management in recent years facilitate the need for accurate and easy-to-use screening methods for early detection of large vessel occlusion (LVO) in acute ischemic stroke (AIS). Our aim was to evaluate the ability of various stroke scales to discriminate an LVO in AIS. We have performed a cross-sectional, observational study based on a registry of consecutive patients with first ever AIS admitted up to 4.5 hours after symptom onset to a comprehensive stroke centre. The diagnostic capability of 14 stroke scales were investigated using receiver operating characteristic (ROC) analysis. Area under the curve (AUC) values of NIHSS, modified NIHSS, shortened NIHSS-EMS, sNIHSS-8, sNIHSS-5 and Rapid Arterial Occlusion Evaluation (RACE) scales were among the highest (>0.800 respectively). A total of 6 scales had cut-off values providing at least 80% specificity and 50% sensitivity, and 5 scales had cut-off values with at least 70% specificity and 75% sensitivity. Certain stroke scales may be suitable for discriminating an LVO in AIS. The NIHSS and modified NIHSS are primarily suitable for use in hospital settings. However, sNIHSS-EMS, sNIHSS-8, sNIHSS-5, RACE and 3-Item Stroke Scale (3I-SS) are easier to perform and interpret, hence their use may be more advantageous in the prehospital setting. Prospective (prehospital) validation of these scales could be the scope of future studies.
Clinical Neuroscience
To prevent ischemic strokes caused by carotid artery stenosis, carotid artery stenting (CAS) and carotid endarterectomy (CEA) have been utilized. However, complications could be linked to either or both procedures. The purpose of our study is to find the most efficient carotid ultrasound method to forecast periprocedural risk (embolization, new neurological symptoms).
Clinical Neuroscience
Prevalence of acute ischemic stroke (AIS) is increased in patients with coronavirus disease 2019 (COVID-19). A proposed hypothesis is increased virus-induced propensity to hypercoagulation resulting in arterial thrombosis. Our aim was to provide evidence regarding the involvement of neutrophil extracellular trap (NET) formation (NETosis) in COVID-19 related AIS. Twenty-six consecutively enrolled COVID-19+ pneumonia patients with AIS, 32 COVID-19+ pneumonia patients without AIS and 24 AIS patients without COVID-19 infection were included to the study. Clinical characteristics of recruited patients were collected. Serum levels of citrullinated histone H3 (H3Cit; a factor of NETosis), IL-8 and C5a (mediators associated with NETosis) were measured by ELISA (enzyme-linked immunosorbent assay). H3Cit levels were significantly higher in COVID-19+ AIS patients, whereas all study groups showed comparable IL-8 and C5a levels. There were no significant differences among etiological subgroups of AIS patients with or without COVID-19. AIS patients with COVID-19 showed relatively increased white blood cell, lymphocyte, neutrophil, D-dimer, C-reactive protein and procalcitonin levels than control groups. H3Cit levels did not correlate with clinical/prognostic features and inflammation parameters. H3Cit and IL-8 levels were correlated in COVID-19 patients without stroke but not in COVID-19 positive or negative AIS patients. Increased levels of inflammation parameters and H3Cit in COVID-19 related AIS suggest that NETosis may cause susceptibility to arterial thrombosis. However, H3Cit levels do not correlate with clinical severity measures and inflammation parameters diminishing the prognostic biomarker value of NETosis factors. Moreover, the link between IL-8 and NETosis appears to be abolished in AIS.
1.
Clinical Neuroscience
[Headache registry in Szeged: Experiences regarding to migraine patients]2.
Clinical Neuroscience
[The new target population of stroke awareness campaign: Kindergarten students ]3.
Clinical Neuroscience
Is there any difference in mortality rates of atrial fibrillation detected before or after ischemic stroke?4.
Clinical Neuroscience
Factors influencing the level of stigma in Parkinson’s disease in western Turkey5.
Clinical Neuroscience
[The effects of demographic and clinical factors on the severity of poststroke aphasia]1.
2.
Clinical Oncology
[Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up]3.
Clinical Oncology
[Pharmacovigilance landscape – Lessons from the past and opportunities for future]4.
5.
